Collaborations with the TGen team on the ABC News

Phoenix Solutions has just started up Proof-of-Concept studies with ACT® together with Translational Genomics Research Institute and the team of Professors Haiyong Han and Daniel Von Hoff.

CEO Per Sontum: “We are very excited to have commenced collaborations with the TGen team of cancer specialists -their expertise on development of novel therapeutic regimes for treatment of pancreatic cancer is, I would say, unprecedented. These studies will form an important part of our pre-clinical development program and we are “on target” to start First-in-Man studies with ACT® 1Q2019”.

Please see ABC news flash (by clicking on the image), and read the news release at TGen`s website here.